|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
| To celebrate PMPS’ 50th issue,Accenture Partner and PMPS Editor Bruce Horton provides an analysis of the industry’s progress since the first edition was published in 1998, and considers where we stand now and the developments that lie ahead. |
|
|
PMPS has seen a wealth of progress in the pharmaceutical world, as well as the full spectrum of economic change and huge strides in R&D.We ask leaders in key sectors to give their views on the future of the industry.
|
|
|
|
Mark Jennings at Dawson Shanahan Ltd introduces coldforming – a technique that can unlock faster and cheaper drug delivery device production – and offers a straightforward means of regulatory compliance.
|
|
|
Andrew Barrow at Cherwell Laboratories points out the importance of an aseptic filling environment for biological products, and shows how the process should be carried out in line with GMP requirements.
|
|
|
Mark Thompson and Sharon Smith at the Honeyman Group Ltd analyse the steam sterilisation process in detail and discuss how a good qualification study is of great importance when demonstrating its effectiveness.
|
|
|
|
|
Suzanne Parish at DHL makes a case for six key elements of communication in the clinical trials supply chain.
|
|
|
Thermal requirements and material restrictions are essential elements of temperature-controlled packaging design, explains Alex Roskoss at Intelsius.
|
|
|
Biological medicines and products present a unique set of challenges for the transporter. Federico Lupp at LifeConEx reviews the steps that must be taken to ensure a smooth journey.
|
|
|
| Kenneth T Lukes at Inmark Inc assesses the recent thermal test standard from ISTA and considers whether it has the potential to be a universally adopted regulation. |
|
|
|
|
Modern manufacturers, as well as the patients they serve, need much more efficient and effective delivery devices than today’s market is able to provide. Phil Lever at Cambridge Consultants picks out ways in which devices can be brought up to scratch.
|
|
|
When bringing a drug delivery device into the US market, there are several considerations to tackle in order to enjoy a fruitful encounter with the patent process, as Clifford M Davidson at Davidson, Davidson & Kappel LLC shows.
|
|
|
The astute drug manufacturer will assess a range of nasal, pulmonary and ophthalmic drug delivery devices to find the right vehicle for their product. Gerallt Williams at Aptar Pharma gives an overview of the various technologies and the features they offer.
|
|
|
Bob Sharp and Paul Whyte at Future Injection Technologies Ltd analyse the future requirements of the NHS for injectables and identify patient behaviour as the key factor in the selection of delivery platforms.
|
|
|
|
|
The pharmaceutical packaging and labelling industry is breaking into new territories more than ever before and with this progress comes the challenge of translation management, as Neil Gleghorn at Kallik explains.
|
|
|
|
|
Adrian Burden at Bilcare Technologies highlights potential technology combinations in today’s devicedriven marketplace, and argues that anti-counterfeiting initiatives should take advantage of the options available to ensure product security.
|
|
|
Joseph Ringwood at Systech International takes a look at aggregation in product tracking, showing that it must be used in conjunction with serialisation in order to achieve a successful track and trace programme.
|
|
|
| Dean Chespy at Siemens Industry Automation explains how the efficiency gains offered by RFID, serialisation and ePedigree initiatives can benefit the whole industry, eliminating human failure and slashing costs as a result. |
|
|
|
| The unique, demanding requirements of protein-based biological products can throw up a range of problems during their formulation. Carsten Olbrich at Bayer Schering Pharma AG looks at how these can be overcome. |
|
|
|
|
| No matter how cool it keeps a product, a thermal packaging solution is no use if it can’t take a knock, as Richard Harrop discovers. |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine
Keele, UK and Matfors, Sweden, 30 March 2020: Cobra Biologics (Cobra), an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet (KI), one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic. Partners in the consortium also include Karolinska University Hospital, Public Health Authority (FoHM), IGEA, Adlego AB and Giessen University.
More info >> |
|
 |
White Papers |
 |
|
Assessing the Integrity of Pharmaceutical Packaging Using the Sepha Blisterscan and Conventional Blue Dye Leak Testing Methods
Sepha Limited
A new whitepaper by a leading packaging expert from the University of Ulster, Dr Dorian Dixon, into the integrity of pharmaceutical packaging has established that existing methods for testing the seal integrity of blister packs are not as accurate as newer, technology based test equipment.
More info >> |
|
 |
Industry Events |
 |
World Vaccine Congress Washington
27-29 September 2020, Walter E Washington Convention Center, Washington, US
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >> |
|
|
